U.S. Pharmaceutical Sales - Q1 2011
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q1 2011. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q1 2011 by sales
- Sales Statistics Q1 2011
- Units*
| Rank |
Drug |
Sales ($000) |
|
|
| 1 |
Lipitor
|
1,909,041 |
n/a |
Stats |
| 2 |
Plavix
|
1,655,111 |
n/a |
Stats |
| 3 |
Nexium
AstraZeneca |
1,553,686 |
n/a |
Stats |
| 4 |
Abilify
Otsuka Pharmaceutical Co., Ltd |
1,232,457 |
n/a |
Stats |
| 5 |
Advair Diskus
GlaxoSmithKline |
1,169,113 |
n/a |
Stats |
| 6 |
Seroquel
AstraZeneca |
1,133,186 |
n/a |
Stats |
| 7 |
Crestor
AstraZeneca |
1,048,141 |
n/a |
Stats |
| 8 |
Singulair
Merck |
1,038,949 |
n/a |
Stats |
| 9 |
Actos
Takeda Pharmaceutical Company Limited |
1,013,886 |
n/a |
Stats |
| 10 |
Cymbalta
|
820,197 |
n/a |
Stats |
| 11 |
Enbrel
Amgen Inc. |
817,401 |
n/a |
Stats |
| 12 |
Remicade
Janssen Pharmaceuticals, Inc. |
804,699 |
n/a |
Stats |
| 13 |
Zyprexa
|
800,446 |
n/a |
Stats |
| 14 |
Humira
AbbVie Inc. |
794,076 |
n/a |
Stats |
| 15 |
Neulasta
Amgen Inc. |
786,288 |
n/a |
Stats |
| 16 |
Copaxone
Teva Pharmaceuticals USA, Inc. |
718,635 |
n/a |
Stats |
| 17 |
OxyContin
Purdue Pharma LP |
706,496 |
n/a |
Stats |
| 18 |
Lexapro
Allergan plc |
698,850 |
n/a |
Stats |
| 19 |
Epogen
Amgen Inc. |
697,224 |
n/a |
Stats |
| 20 |
Rituxan
Genentech, Inc. |
684,666 |
n/a |
Stats |
| 21 |
Avastin
Genentech, Inc. |
658,284 |
n/a |
Stats |
| 22 |
Atripla
Gilead Sciences, Inc. |
587,422 |
n/a |
Stats |
| 23 |
Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc. |
557,860 |
n/a |
Stats |
| 24 |
Lantus
Sanofi |
508,416 |
n/a |
Stats |
| 25 |
Levaquin
Janssen Pharmaceuticals, Inc. |
470,549 |
n/a |
Stats |
| 26 |
Diovan
Novartis Pharmaceuticals Corporation |
469,639 |
n/a |
Stats |
| 27 |
Januvia
Merck |
468,525 |
n/a |
Stats |
| 28 |
Truvada
Gilead Sciences, Inc. |
443,501 |
n/a |
Stats |
| 29 |
Celebrex
|
437,533 |
n/a |
Stats |
| 30 |
Lyrica
|
436,615 |
n/a |
Stats |
| 31 |
venlafaxine
Generic |
430,495 |
n/a |
Stats |
| 32 |
Concerta
Janssen Pharmaceuticals, Inc. |
421,050 |
n/a |
Stats |
| 33 |
Lucentis
Genentech, Inc. |
420,635 |
n/a |
Stats |
| 34 |
Diovan HCT
Novartis Pharmaceuticals Corporation |
404,945 |
n/a |
Stats |
| 35 |
Synagis
MedImmune, Inc. |
403,493 |
n/a |
Stats |
| 36 |
Herceptin
Genentech, Inc. |
384,428 |
n/a |
Stats |
| 37 |
Avonex
Biogen |
370,570 |
n/a |
Stats |
| 38 |
OneTouch
|
359,697 |
n/a |
Stats |
| 39 |
Namenda
Allergan plc |
349,433 |
n/a |
Stats |
| 40 |
Gleevec
Novartis Pharmaceuticals Corporation |
347,690 |
n/a |
Stats |
| 41 |
Lantus Solostar
Sanofi |
333,878 |
n/a |
Stats |
| 42 |
Zetia
Merck |
331,879 |
n/a |
Stats |
| 43 |
TriCor
AbbVie Inc. |
324,053 |
n/a |
Stats |
| 44 |
Geodon
|
323,066 |
n/a |
Stats |
| 45 |
Lovenox
Sanofi |
321,041 |
n/a |
Stats |
| 46 |
donepezil
Generic |
312,985 |
n/a |
Stats |
| 47 |
enoxaparin
Generic |
311,579 |
n/a |
Stats |
| 48 |
Procrit
Janssen Pharmaceuticals, Inc. |
310,606 |
n/a |
Stats |
| 49 |
Vyvanse
Takeda Pharmaceutical Company Limited |
309,394 |
n/a |
Stats |
| 50 |
Niaspan
AbbVie Inc. |
301,309 |
n/a |
Stats |
| 51 |
Aranesp
Amgen Inc. |
294,912 |
n/a |
Stats |
| 52 |
Lidoderm
Endo Pharmaceuticals Inc. |
291,819 |
n/a |
Stats |
| 53 |
Suboxone
|
284,350 |
n/a |
Stats |
| 54 |
Vytorin
Merck |
276,781 |
n/a |
Stats |
| 55 |
Nasonex
Merck |
267,495 |
n/a |
Stats |
| 56 |
AndroGel
AbbVie Inc. |
265,323 |
n/a |
Stats |
| 57 |
Taxotere
Sanofi |
262,205 |
n/a |
Stats |
| 58 |
Combivent
Boehringer Ingelheim Pharmaceuticals, Inc. |
261,226 |
n/a |
Stats |
| 59 |
Viagra
|
255,034 |
n/a |
Stats |
| 60 |
Prevnar 13
Pfizer Inc. |
254,201 |
n/a |
Stats |
| 61 |
Rebif
EMD Serono, Inc. |
253,143 |
n/a |
Stats |
| 62 |
Symbicort
AstraZeneca |
250,905 |
n/a |
Stats |
| 63 |
Adderall XR
Takeda Pharmaceutical Company Limited |
248,516 |
n/a |
Stats |
| 64 |
Flovent HFA
GlaxoSmithKline |
246,705 |
n/a |
Stats |
| 65 |
Lovaza
GlaxoSmithKline |
244,967 |
n/a |
Stats |
| 66 |
Novolog
Novo Nordisk |
244,297 |
n/a |
Stats |
| 67 |
Alimta
Eli Lilly and Company |
242,617 |
n/a |
Stats |
| 68 |
Seroquel XR
AstraZeneca |
242,586 |
n/a |
Stats |
| 69 |
metoprolol
Generic |
238,586 |
n/a |
Stats |
| 70 |
Provigil
|
234,569 |
n/a |
Stats |
| 71 |
Aciphex
Eisai Inc. |
234,407 |
n/a |
Stats |
| 72 |
Humalog
Eli Lilly and Company |
232,809 |
n/a |
Stats |
| 73 |
ProAir HFA
Teva Pharmaceuticals USA, Inc. |
230,795 |
n/a |
Stats |
| 74 |
Neupogen
Amgen Inc. |
230,515 |
n/a |
Stats |
| 75 |
amphetamine/dextroamphetamine
Generic |
230,361 |
n/a |
Stats |
| 76 |
Reyataz
Bristol-Myers Squibb Company |
227,624 |
n/a |
Stats |
| 77 |
budesonide
Generic |
220,600 |
n/a |
Stats |
| 78 |
fentanyl
Generic |
217,863 |
n/a |
Stats |
| 79 |
Lunesta
Sunovion Pharmaceuticals Inc. |
200,317 |
n/a |
Stats |
| 80 |
Levemir
Novo Nordisk |
198,403 |
n/a |
Stats |
| 81 |
Cialis
Eli Lilly and Company |
189,406 |
n/a |
Stats |
| 82 |
Zyvox
Pfizer Inc. |
186,128 |
n/a |
Stats |
| 83 |
valacyclovir
Generic |
184,765 |
n/a |
Stats |
| 84 |
Femara
Novartis Pharmaceuticals Corporation |
184,415 |
n/a |
Stats |
| 85 |
Betaseron
Bayer HealthCare Pharmaceuticals Inc. |
182,908 |
n/a |
Stats |
| 86 |
Tamiflu
|
182,553 |
n/a |
Stats |
| 87 |
Xalatan
|
179,478 |
n/a |
Stats |
| 88 |
Zometa
Novartis Pharmaceuticals Corporation |
177,636 |
n/a |
Stats |
| 89 |
Janumet
Merck |
177,253 |
n/a |
Stats |
| 90 |
Restasis
Allergan plc |
176,652 |
n/a |
Stats |
| 91 |
Evista
|
176,440 |
n/a |
Stats |
| 92 |
Solodyn
Medicis Pharmaceutical Corporation |
175,489 |
n/a |
Stats |
| 93 |
NovoLog FlexPen
Novo Nordisk |
175,235 |
n/a |
Stats |
| 94 |
Benicar
Daiichi Sankyo |
174,621 |
n/a |
Stats |
| 95 |
Erbitux
Eli Lilly and Company |
173,735 |
n/a |
Stats |
| 96 |
azithromycin
Generic |
173,584 |
n/a |
Stats |
| 97 |
bupropion
Generic |
172,612 |
n/a |
Stats |
| 98 |
Detrol LA
Viatris |
170,550 |
n/a |
Stats |
| 99 |
AMLODIP BES/BENAZ
|
170,503 |
n/a |
Stats |
| 100 |
Isentress
Merck |
170,024 |
n/a |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
